Skip to main content
OpenTrials

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,488 public trials 2,849 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Active, not recruiting

Study of Acalabrutinib in Chinese Adult Subjects With Relapsed or Refractory Mantle Cell Lymphoma, Chronic Lymphocytic Leukemia or Other B-cell Malignancies

NCT03932331

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +19 more
Locations
  • Research Site Beijing, China
  • Research Site Beijing, China
  • Research Site Beijing, China
  • Research Site Changchun, China
View all 23 locations
View Trial Details
Active, not recruiting

NKX019, Intravenous Allogeneic Chimeric Antigen Receptor Natural Killer Cells (CAR NK), in Adults With B-cell Cancers

NCT05020678

Conditions
Aggressive Lymphoma, B-cell Acute Lymphoblastic Leukemia, Blood Protein Disorders, +43 more
Locations
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • The Cleveland Clinic Foundation Cleveland, Ohio, United States
  • Institute of Haematology, Royal Prince Alfred Hospital Camperdown, New South Wales, Australia
  • St. Vincent's Hospital Sydney, New South Wales, Australia
View Trial Details
Active, not recruiting

Daratumumab Combined With Bortezomib, Cyclophosphamide and Dexamethasone for the Treatment of Multiple Myeloma Patients Presenting With Extramedullary Disease

NCT04166565

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Extramedullary Plasmacytoma, +13 more
Locations
  • University of Athens Athens, Greece
  • Anticancer Hospital of Thessaloniki Thessaloniki, Greece
  • University of Bologna Bologna, Italy
  • Univerity of Turin Torino, Italy
View Trial Details
Active, not recruiting

Long-Term Safety of Pirtobrutinib in Participants With Previously Treated Types of Blood Cancers

NCT07162181

Conditions
B-cell Lymphoma, Chronic Disease, Disease Attributes, +17 more
Locations
  • Beijing Cancer hospital Beijing, China
  • Sun Yat-sen University Cancer Center Guangzhou, China
  • Harbin Medical University Cancer Hospital Harbin, China
  • Shanghai East Hospital Shanghai, China
View Trial Details

Related conditions